LLGL1 Regulates Gemcitabine Resistance by Modulating the ERK-SP1-OSMR Pathway in Pancreatic Ductal AdenocarcinomaSummary

LLGL1 Regulates Gemcitabine Resistance by Modulating the ERK-SP1-OSMR Pathway in Pancreatic Ductal AdenocarcinomaSummary

Background & Aims: Gemcitabine resistance is rapidly acquired by pancreatic ductal adenocarcinoma (PDAC) patients. Novel approaches that predict the gemcitabine response of patients and enhance gemcitabine chemosensitivity are important to improve patient survival. We aimed to identify genes...

Full description

Bibliographic Details
Main Authors: Yin-Xin Zhu, Chi Han Li, Guolin Li, Huiyi Feng, Tian Xia, Chi Hin Wong, Frederic Khe Cheong Fung, Joanna Hung-Man Tong, Ka-Fai To, Rufu Chen, Yangchao Chen
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Cellular and Molecular Gastroenterology and Hepatology
Subjects:
Pancreatic Cancer
Gemcitabine
Oncostatin M Receptor
SP1 Signaling
Online Access:http://www.sciencedirect.com/science/article/pii/S2352345X20300989

Internet

http://www.sciencedirect.com/science/article/pii/S2352345X20300989

Similar Items